Literature DB >> 19682479

Arsenic exacerbates atherosclerotic lesion formation and inflammation in ApoE-/- mice.

Sanjay Srivastava1, Elena N Vladykovskaya, Petra Haberzettl, Srinivas D Sithu, Stanley E D'Souza, J Christopher States.   

Abstract

Exposure to arsenic-contaminated water has been shown to be associated with cardiovascular disease, especially atherosclerosis. We examined the effect of arsenic exposure on atherosclerotic lesion formation, lesion composition and nature in ApoE-/- mice. Early post-natal exposure (3-week-old mice exposed to 49 ppm arsenic as NaAsO(2) in drinking water for 7 weeks) increased the atherosclerotic lesion formation by 3- to 5-fold in the aortic valve and the aortic arch, without affecting plasma cholesterol. Exposure to arsenic for 13 weeks (3-week-old mice exposed to 1, 4.9 and 49 ppm arsenic as NaAsO(2) in drinking water) increased the lesion formation and macrophage accumulation in a dose-dependent manner. Temporal studies showed that continuous arsenic exposure significantly exacerbated the lesion formation throughout the aortic tree at 16 and 36 weeks of age. Withdrawal of arsenic for 12 weeks after an initial exposure for 21 weeks (to 3-week-old mice) significantly decreased lesion formation as compared with mice continuously exposed to arsenic. Similarly, adult exposure to 49 ppm arsenic for 24 weeks, starting at 12 weeks of age increased lesion formation by 2- to 3.6-fold in the aortic valve, the aortic arch and the abdominal aorta. Lesions of arsenic-exposed mice displayed a 1.8-fold increase in macrophage accumulation whereas smooth muscle cell and T-lymphocyte contents were not changed. Expression of pro-inflammatory chemokine MCP-1 and cytokine IL-6 and markers of oxidative stress, protein-HNE and protein-MDA adducts were markedly increased in lesions of arsenic-exposed mice. Plasma concentrations of MCP-1, IL-6 and MDA were also significantly elevated in arsenic-exposed mice. These data suggest that arsenic exposure increases oxidative stress, inflammation and atherosclerotic lesion formation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19682479      PMCID: PMC4414341          DOI: 10.1016/j.taap.2009.08.004

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  45 in total

1.  Contribution of aldose reductase to diabetic hyperproliferation of vascular smooth muscle cells.

Authors:  Sanjay Srivastava; Kota V Ramana; Ravinder Tammali; Satish K Srivastava; Aruni Bhatnagar
Journal:  Diabetes       Date:  2006-04       Impact factor: 9.461

Review 2.  Vascular effects of chronic arsenic exposure: a review.

Authors:  R R Engel; C Hopenhayn-Rich; O Receveur; A H Smith
Journal:  Epidemiol Rev       Date:  1994       Impact factor: 6.222

Review 3.  A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases.

Authors:  Chih-Hao Wang; Chuhsing Kate Hsiao; Chi-Ling Chen; Lin-I Hsu; Hung-Yi Chiou; Shu-Yuan Chen; Yu-Mei Hsueh; Meei-Maan Wu; Chien-Jen Chen
Journal:  Toxicol Appl Pharmacol       Date:  2006-12-30       Impact factor: 4.219

4.  Risk of carotid atherosclerosis associated with genetic polymorphisms of apolipoprotein E and inflammatory genes among arsenic exposed residents in Taiwan.

Authors:  Yi-Chen Hsieh; Fang-I Hsieh; Li-Ming Lien; Yi-Li Chou; Hung-Yi Chiou; Chien-Jen Chen
Journal:  Toxicol Appl Pharmacol       Date:  2007-10-22       Impact factor: 4.219

Review 5.  Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan.

Authors:  Chin-Hsiao Tseng
Journal:  Atherosclerosis       Date:  2008-02-21       Impact factor: 5.162

Review 6.  Arsenic and cardiovascular disease.

Authors:  J Christopher States; Sanjay Srivastava; Yu Chen; Aaron Barchowsky
Journal:  Toxicol Sci       Date:  2008-11-17       Impact factor: 4.849

7.  Elevated levels of interleukin-6 in unstable angina.

Authors:  L M Biasucci; A Vitelli; G Liuzzo; S Altamura; G Caligiuri; C Monaco; A G Rebuzzi; G Ciliberto; A Maseri
Journal:  Circulation       Date:  1996-09-01       Impact factor: 29.690

8.  IL-6 is produced by splenocytes derived from CMV-infected mice in response to CMV antigens, and induces MCP-1 production by endothelial cells: a new mechanistic paradigm for infection-induced atherogenesis.

Authors:  David Rott; Jianhui Zhu; Yi Fu Zhou; Mary Susan Burnett; Alexandra Zalles-Ganley; Stephen E Epstein
Journal:  Atherosclerosis       Date:  2003-10       Impact factor: 5.162

9.  Arsenic exposure accelerates atherogenesis in apolipoprotein E(-/-) mice.

Authors:  Petia P Simeonova; Tracy Hulderman; Dan Harki; Michael I Luster
Journal:  Environ Health Perspect       Date:  2003-11       Impact factor: 9.031

Review 10.  Cytokines and atherosclerosis: a comprehensive review of studies in mice.

Authors:  Robert Kleemann; Susanne Zadelaar; Teake Kooistra
Journal:  Cardiovasc Res       Date:  2008-05-16       Impact factor: 10.787

View more
  35 in total

1.  Exposure to moderate arsenic concentrations increases atherosclerosis in ApoE-/- mouse model.

Authors:  Maryse Lemaire; Catherine A Lemarié; Manuel Flores Molina; Ernesto L Schiffrin; Stéphanie Lehoux; Koren K Mann
Journal:  Toxicol Sci       Date:  2011-04-21       Impact factor: 4.849

Review 2.  Influence of arsenate and arsenite on signal transduction pathways: an update.

Authors:  Ingrid L Druwe; Richard R Vaillancourt
Journal:  Arch Toxicol       Date:  2010-05-26       Impact factor: 5.153

Review 3.  Environmental factors in cardiovascular disease.

Authors:  Kristen E Cosselman; Ana Navas-Acien; Joel D Kaufman
Journal:  Nat Rev Cardiol       Date:  2015-10-13       Impact factor: 32.419

Review 4.  Cardiovascular effects of arsenic: clinical and epidemiological findings.

Authors:  Francesco Stea; Fabrizio Bianchi; Liliana Cori; Rosa Sicari
Journal:  Environ Sci Pollut Res Int       Date:  2013-09-10       Impact factor: 4.223

5.  Cardiac epithelial-mesenchymal transition is blocked by monomethylarsonous acid (III).

Authors:  Tianfang Huang; Joey V Barnett; Todd D Camenisch
Journal:  Toxicol Sci       Date:  2014-08-21       Impact factor: 4.849

6.  Low-level arsenic causes chronic inflammation and suppresses expression of phagocytic receptors.

Authors:  Priyanka Prasad; Dona Sinha
Journal:  Environ Sci Pollut Res Int       Date:  2017-03-22       Impact factor: 4.223

7.  Arsenite Disrupts Zinc-Dependent TGFβ2-SMAD Activity During Murine Cardiac Progenitor Cell Differentiation.

Authors:  Tianfang Huang; Eric J Ditzel; Alec B Perrera; Derrick M Broka; Todd D Camenisch
Journal:  Toxicol Sci       Date:  2015-09-08       Impact factor: 4.849

8.  Genetic deletion of LXRα prevents arsenic-enhanced atherosclerosis, but not arsenic-altered plaque composition.

Authors:  Maryse Lemaire; Catherine A Lemarié; Manuel Flores Molina; Cynthia Guilbert; Stéphanie Lehoux; Koren K Mann
Journal:  Toxicol Sci       Date:  2014-09-30       Impact factor: 4.849

Review 9.  In utero and early life arsenic exposure in relation to long-term health and disease.

Authors:  Shohreh F Farzan; Margaret R Karagas; Yu Chen
Journal:  Toxicol Appl Pharmacol       Date:  2013-07-13       Impact factor: 4.219

10.  Arsenic Exposure and Subclinical Endpoints of Cardiovascular Diseases.

Authors:  Fen Wu; Peter Molinaro; Yu Chen
Journal:  Curr Environ Health Rep       Date:  2014-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.